The Effects of Cardiometabolic Comorbidities on Biologic Treatment for Psoriasis with Respect to PASI Scores: A Qualitative Systematic Review.
Alim OsmanAlexandra NigroAmanda Chen TaylorRyan SaalAna Ormaza VeraClinton EnosPublished in: Psoriasis (Auckland, N.Z.) (2024)
Relationships between cardiometabolic risk factors and lower frequencies of achieving PASI75/90 exist in current literature. This qualitative systematic review reports evidence of lower PASI75 and PASI90 response rates in the presence of cardiometabolic risk factors.